<span class=postbold>See Also</span>: Valley reacts to Marijuana pill approval
<span class=postbold>See Also</span>: OK from the FDA for synthetic marijuana drug
The Orange County Business Journal wrote:
Valeant Launches Cesamet Trial
August 26, 2006
The Orange County Business Journal
Valeant Pharmaceuticals International, the Costa Mesa-based drug maker, just launched its Cesamet anti-vomiting drug in the U.S. Now the company wants to know how patients do with it.
Valeant said earlier this month it would explore “the patient benefit in using Cesamet to control chemotherapy-induced nausea and vomiting” and how it might affect such patients’ quality of life.
The trial will look at 40 patients who are receiving treatment for non-small cell lung cancer, breast cancer or colorectal cancer and who haven’t adequately responded to traditional treatments.
The FDA approved Cesamet to treat nausea associated with chemotherapy in May. Cesamet is a cannabinoid, or synthetic chemical based on tetrahydrocannabinol, the active ingredient in marijuana.
Valeant acquired Cesamet in 2004 from Eli Lilly & Co.